The Effect of the Use of Artificial Intelligence in the Preparation of Patient Education Material

July 21, 2024 updated by: Sevda Korkut, TC Erciyes University

The Effect of the Use of Artificial Intelligence in the Preparation of Patient Education Material on the Comprehensibility, Actionability and Quality of the Material

This research was conducted to examine the effect of students' use of AI tools while preparing patient education material on the quality, understandability and actionability of the material in terms of content. Students in the control group used auxiliary tools such as books, journals and websites while preparing patient education materials. Students in the intervention group used AI tools in addition to tools such as books, journals, and websites.

Study Overview

Detailed Description

This research was conducted to examine the effect of students' use of AI tools while preparing patient education material on the quality, understandability and actionability of the material in terms of content. Students in the control group used auxiliary tools such as books, journals and websites while preparing patient education materials. Students in the intervention group used AI tools in addition to tools such as books, journals, and websites. Patient Education Materials Assessment Tool and Global Quality Scale were used to evaluate the educational materials.

Study Type

Interventional

Enrollment (Actual)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kayseri
      • Talas, Kayseri, Turkey, 0(553) 310 49 51
        • Sevda Korkut

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • agreeing to participate in the study,
  • taking the Fundamentals of Nursing II course for the first time,
  • not working as a nurse in a hospital or any health institution.

Exclusion Criteria:

  • not agreeing to participate in the study
  • having prepared patient education materials before
  • repeating the Fundamentals of Nursing II course
  • not having internet access
  • not having a computer or smartphone.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Group using artificial intelligence tools in addition to traditional tools in preparing educational materials
Students in the intervention group used AI tools in addition to tools such as books, journals, and websites.
Other Names:
  • artificial intelligence
No Intervention: Control group
Group using traditional tools in preparing educational materials

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Understandability of the material
Time Frame: After the students have completed the materials (5 days later)
Patient Education Materials Assessment Tool for Printable Materials: The tool consists of a total of 26 items, 19 items evaluating the understandability of the materials and 7 items evaluating their actionability. PEMAT scores materials from 0 to 100 points for understandability and actionability.
After the students have completed the materials (5 days later)
Actionability of the material
Time Frame: After the students have completed the materials (5 days later)
Patient Education Materials Assessment Tool for Printable Materials: The tool consists of a total of 26 items, 19 items evaluating the understandability of the materials and 7 items evaluating their actionability. PEMAT scores materials from 0 to 100 points for understandability and actionability.
After the students have completed the materials (5 days later)
Quality of the material
Time Frame: After the students have completed the materials (5 days later)
Global Quality Scale : According to this scale, the quality of the training materials was evaluated on a 5-point scale (1: poor quality, 2: low quality - limited use, 3: somewhat useful, 4: useful, 5: useful-excellent quality).
After the students have completed the materials (5 days later)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: SEVDA KORKUT, TC Erciyes University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 5, 2024

Primary Completion (Actual)

May 31, 2024

Study Completion (Actual)

June 7, 2024

Study Registration Dates

First Submitted

July 21, 2024

First Submitted That Met QC Criteria

July 21, 2024

First Posted (Actual)

July 25, 2024

Study Record Updates

Last Update Posted (Actual)

July 25, 2024

Last Update Submitted That Met QC Criteria

July 21, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2024-04/14

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Artificial Intelligence

Subscribe